MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 157 filers reported holding MOMENTA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,470,000 | +36.7% | 44,191 | +11.8% | 0.03% | +20.0% |
| Q1 2020 | $1,075,000 | +37.8% | 39,530 | 0.0% | 0.02% | +66.7% |
| Q4 2019 | $780,000 | +79.7% | 39,530 | +17.9% | 0.02% | +66.7% |
| Q3 2019 | $434,000 | +5.9% | 33,516 | +1.8% | 0.01% | 0.0% |
| Q2 2019 | $410,000 | -10.9% | 32,916 | +4.0% | 0.01% | -10.0% |
| Q1 2019 | $460,000 | +39.8% | 31,637 | +6.1% | 0.01% | +25.0% |
| Q4 2018 | $329,000 | -46.1% | 29,813 | +28.5% | 0.01% | -38.5% |
| Q3 2018 | $610,000 | +33.2% | 23,205 | +3.6% | 0.01% | +30.0% |
| Q2 2018 | $458,000 | +18.3% | 22,406 | +5.1% | 0.01% | +11.1% |
| Q1 2018 | $387,000 | +39.7% | 21,321 | +7.3% | 0.01% | +50.0% |
| Q4 2017 | $277,000 | -22.4% | 19,867 | +2.9% | 0.01% | -33.3% |
| Q3 2017 | $357,000 | +28.4% | 19,307 | +17.2% | 0.01% | +28.6% |
| Q2 2017 | $278,000 | +37.6% | 16,468 | +8.9% | 0.01% | +40.0% |
| Q1 2017 | $202,000 | -3.8% | 15,122 | +8.3% | 0.01% | -16.7% |
| Q4 2016 | $210,000 | +39.1% | 13,968 | +8.5% | 0.01% | +50.0% |
| Q3 2016 | $151,000 | +12.7% | 12,876 | +4.1% | 0.00% | 0.0% |
| Q2 2016 | $134,000 | +31.4% | 12,363 | +12.1% | 0.00% | +33.3% |
| Q1 2016 | $102,000 | -32.0% | 11,032 | +9.2% | 0.00% | -40.0% |
| Q4 2015 | $150,000 | -0.7% | 10,102 | +9.5% | 0.01% | 0.0% |
| Q3 2015 | $151,000 | -19.3% | 9,226 | +12.3% | 0.01% | -16.7% |
| Q2 2015 | $187,000 | +90.8% | 8,214 | +27.9% | 0.01% | +100.0% |
| Q1 2015 | $98,000 | -94.0% | 6,423 | -95.2% | 0.00% | -72.7% |
| Q4 2014 | $1,625,000 | +6.3% | 135,006 | +0.2% | 0.01% | -8.3% |
| Q3 2014 | $1,529,000 | -4.6% | 134,799 | -0.0% | 0.01% | 0.0% |
| Q2 2014 | $1,603,000 | +4.5% | 134,835 | +2.4% | 0.01% | 0.0% |
| Q1 2014 | $1,534,000 | -34.9% | 131,639 | -1.3% | 0.01% | -36.8% |
| Q4 2013 | $2,357,000 | +2329.9% | 133,320 | +1870.7% | 0.02% | +1800.0% |
| Q3 2013 | $97,000 | +2.1% | 6,765 | +6.9% | 0.00% | 0.0% |
| Q2 2013 | $95,000 | – | 6,331 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MONROE HALL ASSET MANAGEMENT LLC | 200,000 | $3,282,000 | 1.60% |
| SECTOR GAMMA AS | 350,920 | $5,759,000 | 1.56% |
| Opaleye Management Inc. | 160,000 | $2,626,000 | 1.29% |
| Visium Asset Management, LP | 5,398,088 | $88,583,000 | 1.21% |
| Palo Alto Investors LP | 1,455,176 | $23,879,000 | 1.15% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 4,597,915 | $75,452,000 | 0.84% |
| Sivik Global Healthcare LLC | 90,000 | $1,477,000 | 0.72% |
| Campbell & CO Investment Adviser LLC | 45,887 | $753,000 | 0.50% |
| Apex Capital Management | 1,096,757 | $17,998,000 | 0.41% |
| AlphaMark Advisors, LLC | 42,651 | $700,000 | 0.39% |